GLP-1 drugs for weight loss, such as Ozempic and Wegovy, have become wildly popular. A recent Gallup poll says 11% of U.S. adults are currently taking a GLP-1 medication to lose weight, up from 3% two years ago.

Two critical phase 3 trials conducted by researchers at Northwestern University found that high doses of a new drug had an unexpected benefit.

A new study suggests menopause hormone therapy may enhance weight loss in women taking GLP-1 medications. Here's what Black women should know.

Eli Lilly reported results from new studies exploring the effects of its GLP-1 weight-loss drugs on sleep apnea and arthritis.

New trials show retatrutide may deliver significant weight loss and knee osteoarthritis pain relief, improving mobility and metabolic health.

US is requiring weight-loss drug makers to warn about possible loss of eyesight - Nearly 30 million Americans are taking weight-loss drugs

The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label about a possible link to permanent vision loss, the US Food and Drug Administration has said. Older age people,

Weight-loss medications may help reduce body fat, but preserving muscle is equally important. Here's why resistance training could be essential for maintaining strength and improving body composition during weight loss.

Whether you are in a weight loss plateau is determined not by the individual daily measurement points, but by the direction of the line that smooths out the fluctuations. Even if the points move up and down,